Książka ePro Brian Tiplady

ePro

Autor: Brian Tiplady
Język: Angielski
Oprawa: Twarda
Dostępność: 50 % szansa
Przeszukamy cały świat
887.23
Patient self-reported data has become increasingly important in today's clinical trials. Trials in s...

Informacje o książce

Język
Angielski
Oprawa
Książka - Twarda
Data wydania
2010
strony
296
EAN
9780566087714
ISBN
0566087715
Enbook ID
04621885
Waga
790
Wymiary
179 x 252 x 24

Pełny opis

Patient self-reported data has become increasingly important in today's clinical trials. Trials in some disease indications rely upon patient recorded diary data as the primary endpoint to demonstrate drug efficacy - including, for example, indications such as insomnia, migraine and pain. In addition, improvements in quality of life measured using patient questionnaires can now be included as claims on drug labelling. Traditionally these data have been collected using paper questionnaires and diaries issued to subjects. Regulators and the industry have become increasingly aware of the limitations of recording patient reported outcomes data on paper including data quality and integrity issues. As a result there is a growing interest in collection of patient reported outcomes data using electronic means (ePRO). Solutions include handheld PDAs, Interactive Voice Response (IVR) systems, and other site-based hardware such as touchscreen PCs. Recently, there has been much open debate with the regulators around the use of ePRO in clinical drug submissions. US and European agencies have approved new drugs that have included ePRO data in the submission dossier, but there are many questions around the adoption of the technology that concern the community. These include: How should instruments developed on paper be adapted for electronic use, and what degree of validation should be done between paper and electronic forms? How can researchers ensure they are complying with regulatory requirements including the PRO guidance published by FDA in 2009 when using ePRO solutions? Can fewer patients be exposed in a clinical trial as a result of improved data quality obtained using electronic diaries? What type of solution should be used for certain patient populations and protocols, and how can ePRO solutions be designed optimally to increase patient acceptability and compliance? Bill Byrom and Brian Tiplady's "ePro" addresses all these issues, reviews the new FDA guidance, and provides a very contemporary view on this important subject.

Możesz być zainteresowany

92.35
56.48
34.60

Little Tarts

Meike Schaling
87.20
34.60

Back to the '30s?

Jeremy Rayner
567.08

The Art of Death Stranding

Kojima Productions
113.54

Church Needlework

Hinda M. Hinds
80.97

Twisted Games

Ana Huang
41.21

Berserk Volume 40

Kentaro Miura
49.67
94.98
78.06
40.05
34.60

The Legacy

Elle Kennedy
61.72

Klienci, którzy kupili tę książkę, kupili również

Síla rodu v nás

Oksana Solodovnikovová
43.74

Einaudi (Un)Discovered

Ludovico Einaudi
82.43
29.35

Il Piccolo Principe

Antoine de Saint-Exupery
15.84

Ars brevis

Alexander Fidora
73.68
59.59
52.10